FIGURE 3 from Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry
Year: 2024
Type: other
Abstract: PFS from initiation of first-line cancer-directed regimen (A, PM vs. non-PM; B, PM only vs. PM and other sites vs. non-PM; C, stage IV: PM only vs. PM and other sites vs. non-PM; D, stage I–III with later development of distant metastasis: PM vs. non-PM).
Authors: Enrique Sanz-Garcia, Samantha Brown, Jessica A. Lavery, Jessica Weiss, Hannah E. Fuchs, Ashley Newcomb, Asha Postle, Jeremy L. Warner, Michele L. LeNoue-Newton, Shawn M. Sweeney, Shirin Pillai, Celeste Yu, Chelsea Nichols, Brooke Mastrogiacomo, Ritika Kundra, Nikolaus Schultz, Kenneth L. Kehl, Gregory J. Riely, Deborah Schrag, Anand Govindarajan, Katherine S. Panageas, Philippe L. Bedard
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4391979899